ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

POLB Poolbeg Pharma Plc

13.70
0.60 (4.58%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Poolbeg Pharma Plc LSE:POLB London Ordinary Share GB00BKPG7Z60 ORD 0.02P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.60 4.58% 13.70 13.50 13.90 13.70 13.10 13.10 959,988 14:58:30
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 0 -4.69M -0.0094 -14.57 68.5M
Poolbeg Pharma Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker POLB. The last closing price for Poolbeg Pharma was 13.10p. Over the last year, Poolbeg Pharma shares have traded in a share price range of 6.55p to 15.70p.

Poolbeg Pharma currently has 500,000,000 shares in issue. The market capitalisation of Poolbeg Pharma is £68.50 million. Poolbeg Pharma has a price to earnings ratio (PE ratio) of -14.57.

Poolbeg Pharma Share Discussion Threads

Showing 2426 to 2447 of 3400 messages
Chat Pages: Latest  100  99  98  97  96  95  94  93  92  91  90  89  Older
DateSubjectAuthorDiscuss
07/6/2023
18:26
A couple of large late reported shares could be them.
mark10101
06/6/2023
15:37
Very encouraging that the 115,000 shares offered at 8.30p in the 2 pm auction got picked up.
klosters65
05/6/2023
12:23
Just seen that their was a trade Friday afternoon for 901,332 shares at 8.20p.
klosters65
05/6/2023
08:47
I am pleased to see that the share price is continuing to firm up.
klosters65
02/6/2023
09:24
Are we on the move?
klosters65
01/6/2023
12:21
That is a decent buy.
rafboy
01/6/2023
12:02
Damn nice trade yesterday at 3:37..

1.5 Mill at 7.92p

chica1
31/5/2023
13:30
Forbes:Data mining..

I particularly like this paragraph.


Unearthing data by a citizen developer can keep century-old companies alive by taking their wealth of knowledge and applying it going forward. Historical data can define how they make money while guiding the future. Using this data can present new opportunities and skyrocketing revenues. Enterprises with the ability to harness big data can support new revenue streams and create spin-offs, new departments or new services.

chica1
31/5/2023
08:59
Oh sure Klosters he was telling us over on HVO's forum that Mo was holding back news to let an institutional investor accumulate.
chica1
31/5/2023
08:15
Trout, You make it sound like a precise piece of engineering. And that is gospel. Believe me it is not. Much can happen between the bid and offer and occasionally the punters can mix with the market makers.
klosters65
30/5/2023
22:05
klosters,
The price is made as a bid and an offer, the MMs bid for your shares and offer you shares at a higher price.
The punter buys at the offer price and sells at the bid price.

troutisout
30/5/2023
14:54
Definitely a buy at 7.20p. Now 7.2O Buy. /. 7.50. Ask.
klosters65
28/5/2023
21:35
Well Ex isn't that when he was doing his monthly fireside chats,2021??
chica1
27/5/2023
07:49
He thinks this is an AI share. Lmao.
It's only the ones that make the algorithms/models/platforms and hardware that count as AI shares.

ih_486726
26/5/2023
16:34
AI shares exploding upwards because of Nvidia's quarter.
Would have been nice to get some AI news in the current climate.

chica1
26/5/2023
14:05
OneTree news is not due until H2,not Q2.


Many thanks for your email enquiry.



We have stated publicly we are progressing the drug candidates identified in our OneThree RSV AI programme into lab-based validation and I can confirm that we are on track to announce our progress on this in H2, as per our stated timeline.



Keeping to our projected timelines is something that the Poolbeg team takes very seriously, and we aim to continue achieving these. With that in mind, we expect the outputs to the OneThree AI programme to be delivered on schedule.



Please do not hesitate to contact us should you have any further questions or queries.



Kind regards,



Investor Relations

chica1
26/5/2023
12:27
See post 2429. I'm not privileged to anything that has not been released to the market.
klosters65
26/5/2023
12:20
What news klosters?
chica1
26/5/2023
11:54
Pretty convinced that there is not much time left to buy at the current price. Bid is firming up and news must be due shortly.
klosters65
26/5/2023
11:21
1gw no doubt he's an intelligent guy but yeah who's pulling the strings.

Then again imho most board members are futile, so if he's willing to put the time in (and he does) that's a major asset to have.

chica1
26/5/2023
10:33
I think I would prefer to have as an independent NED someone who didn't have quite so much history with Open Orphan (and therefore presumably with CF, the major shareholder of POLB).
1gw
26/5/2023
10:15
When are we expecting news from the collaboration with Onetree?

Brendan Buckley has been a director at (OO)Hvivo for the last 3 years so no surprise there.
He's also a director at Imutex.

Obviously he's Cathal Friel's goto guy in the medical space.

chica1
Chat Pages: Latest  100  99  98  97  96  95  94  93  92  91  90  89  Older

Your Recent History

Delayed Upgrade Clock